Is AUBAGIO oral?

Aubagio® (teriflunomide), a pyrimidine synthesis inhibitor, is an oral compound that inhibits the function of specific immune cells that have been implicated in MS. It is related to leflunomide, a drug used to treat rheumatoid arthritis.

Is teriflunomide an immunosuppressant?

Results: Teriflunomide and Cladribine are second-generation immunosuppressants that are efficient in the treatment of MS patients. For Teriflunomide, a daily dose of 14 mg reduces the annualized relapse rate (ARR) by more than 30% and disability progression by 30% compared to placebo.

Is AUBAGIO good for MS?

AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. or without food.

What are oral treatments for MS?

Three oral drugs have been approved by regulatory agencies for the treatment of MS: fingolimod, teriflunomide, and dimethyl fumarate.

What type of drug is teriflunomide?

Teriflunomide is in a class of medications called immunomodulatory agents. It is thought to work by decreasing inflammation and decreasing the action of immune cells that may cause nerve damage.

What is teriflunomide used for?

Generic Name: teriflunomide This medication is used by adults to treat multiple sclerosis-MS. It is not a cure for MS but is thought to work by decreasing certain immune system cells (lymphocytes) which can attack the nerves in your brain and spinal cord.

What is the safest oral medication for MS?

But Copaxone, FDA-approved in 1996, scored best on measures of several side effects, including cognitive disorders and flu-like symptoms, making it the safest of the older first-line MS drugs.

Can teriflunomide help relapsing MS patients?

Teriflunomide, the active metabolite of leflunomide, is being investigated as a new oral disease-modifying therapy for relapsing forms of multiple sclerosis. Although the two drugs are related in structure, teriflunomide has a distinct profile.

What is the teriflunomide oral trial?

To add to the results reported in the TEMSO trial, we undertook the phase 3 Teriflunomide Oral in People With Relapsing Multiple Sclerosis (TOWER) trial to assess the safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis.

Is teriflunomide safe to take?

Teriflunomide is generally a well-tolerated drug, with predominately mild to moderate AEs and only rare serious adverse events (SAEs). In the phase II clinical trial, there was a similar incidence of AEs across the placebo and teriflunomide arms.

Is teriflunomide an effective add-on therapy to glatiramer acetate?

The utility of teriflunomide as add-on therapy to glatiramer acetate (GA) has been assessed in a multicenter, randomized, placebo-controlled, double-blind clinical trial of 123 relapsing MS patients on a stable dose of GA (>26 weeks).